1. Sesen Bio Announces Changes to the Board of Directors as the Company Advances Toward Commercialization of Vicinium®

    Sesen Bio Announces Changes to the Board of Directors as the Company Advances Toward Commercialization of Vicinium®

    Sesen Bio (NasdaqSESN) a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced the appointment of Carrie Bourdow, chief executive officer of Trevena, Inc., and Jason Keyes, chief financial officer of Equillium, to the Company’s Board of Directors...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Question of The Week, Sponsored Content
  2. Topics Mentioned